KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Xenon Pharmaceuticals (XENE) Interest & Investment Income: 2012-2024

Historic Interest & Investment Income for Xenon Pharmaceuticals (XENE) over the last 13 years, with Dec 2024 value amounting to $41.9 million.

  • Xenon Pharmaceuticals' Interest & Investment Income fell 39.92% to $6.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.9 million, marking a year-over-year decrease of 25.00%. This contributed to the annual value of $41.9 million for FY2024, which is 51.86% up from last year.
  • Per Xenon Pharmaceuticals' latest filing, its Interest & Investment Income stood at $41.9 million for FY2024, which was up 51.86% from $27.6 million recorded in FY2023.
  • In the past 5 years, Xenon Pharmaceuticals' Interest & Investment Income ranged from a high of $41.9 million in FY2024 and a low of $466,000 during FY2021.
  • Over the past 3 years, Xenon Pharmaceuticals' median Interest & Investment Income value was $27.6 million (recorded in 2023), while the average stood at $26.1 million.
  • Per our database at Business Quant, Xenon Pharmaceuticals' Interest & Investment Income slumped by 79.55% in 2021 and then soared by 1,769.74% in 2022.
  • Yearly analysis of 5 years shows Xenon Pharmaceuticals' Interest & Investment Income stood at $2.3 million in 2020, then plummeted by 79.55% to $466,000 in 2021, then skyrocketed by 1,769.74% to $8.7 million in 2022, then soared by 217.00% to $27.6 million in 2023, then surged by 51.86% to $41.9 million in 2024.